Funds and ETFs Sun Pharmaceutical Industries Ltd.

SUNPHARMA

INE044A01036

Name	Weight	AuM	1st Jan change	Investor Rating
WISDOMTREE INDIA EX-STATE-OWNED ENTERPRISES FUND ETF - USD	1.72%	6 M€	+6.07%	-
HARTFORD MULTIFACTOR EMERGING MARKETS ETF - USD	0.42%	0 M€	+6.25%
AMUNDI INDEX MSCI EMERGING MARKETS UCITS ETF DR (C) - EUR	0.20%	0 M€	+8.13%	-
AMUNDI INDEX MSCI EMERGING MARKETS UCITS ETF - USD	0.20%	0 M€	+5.56%	-
AMUNDI INDEX MSCI EMERGING MARKETS UCITS ETF DR (D) - EUR	0.20%	0 M€	+7.38%	-
RBC QUANT EMERGING MARKETS EQUITY LEADERS ETF - CAD	0.20%	3 M€	-.--%	-
RBC QUANT EMERGING MARKETS EQUITY LEADERS ETF - USD	0.20%	1 M€	+3.49%	-
SIMPLIFY EMERGING MARKETS PLUS DOWNSIDE CONVEXITY ETF - USD	0.17%	4 M€	-4.41%	-
LEADERSHARES EQUITY SKEW ETF - USD	0.13%	0 M€	+3.30%	-
GOLDMAN SACHS ACTIVEBETA EMERGING MARKETS EQUITY UCITS ETF - ACC - USD	0.11%	0 M€	+4.62%
DAY HAGAN/NED DAVIS RESEARCH SMART SECTOR INTERNATIONAL ETF - USD	0.08%	0 M€	+5.99%	-
LEVERAGE SHARES 3X LONG TOTAL WORLD ETP SECURITIES - USD	0.05%	0 M€	0.00%	-
DEMOCRACY INTERNATIONAL FUND ETF - USD	0.05%	0 M€	+4.28%	-
SPROTT JUNIOR COPPER MINERS ETF - USD	0.05%	0 M€	+25.22%	-
NOMURA NEXT FUNDS EMERGING MARKET EQUITY MSCI-EM (UNHEDGED) ETF - JPY	0.03%	0 M€	+14.35%
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD	0.02%	0 M€	+3.53%	-
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF - DISTRIBUTING - EUR	0.02%	0 M€	+7.77%	-
VANGUARD LIFESTRATEGY 80% EQUITY UCITS ETF ACC - EUR	0.02%	0 M€	+8.18%	-
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - DISTRIBUTING - EUR	0.02%	0 M€	+4.96%	-
VANGUARD LIFESTRATEGY 60% EQUITY UCITS ETF - ACC - EUR	0.02%	0 M€	+5.61%	-
VANGUARD LIFESTRATEGY 40% EQUITY UCITS ETF ACC - EUR	0.01%	0 M€	+3.46%	-
HAN-GINS INDXX HEALTHCARE MEGATREND EQUAL WEIGHT UCITS ETF - ACC - USD	0.01%	0 M€	-3.76%
VANGUARD LIFESTRATEGY 40% EQUITY UCITS ETF - DISTRIBUTING - EUR	0.01%	0 M€	+2.65%	-

Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows: - generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment; - other (6%) : primarily active pharmaceutical ingredients. At the end of March 2021, the group had 44 production plants worldwide. Net sales are distributed geographically as follows: India (33%), the United States (31.3%), other (35.7%).

Sector

Pharmaceuticals

Calendar

2024-05-23 - Q4 2024 Earnings Release (Projected)

Related indices

NIFTY 50 , NIFTY 100

More about the company

Income Statement Evolution

More financial data

Ratings for Sun Pharmaceutical Industries Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1,515 INR

Average target price

1,574 INR

Spread / Average Target

+3.85%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.30%	43.57B
OTSUKA HOLDINGS CO., LTD.	+20.70%	22.7B
SANDOZ GROUP AG	+16.41%	14.32B
CIPLA LIMITED	+11.12%	13.42B
ZYDUS LIFESCIENCES LIMITED	+45.89%	11.83B
ONO PHARMACEUTICAL CO., LTD.	-8.84%	6.98B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+12.33%	5.51B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-3.58%	4.76B

Generic Pharmaceuticals

Delayed NSE India S.E. Other stock markets 05:19:16 2024-05-08 am EDT			5-day change	1st Jan Change
1,516 ^INR	+0.04%		-0.25%	+20.30%

May. 04	Sun Pharmaceutical Industries Limited entered into an agreement to acquire Valstar Investment S.a. for an enterprise value of $31 million.	CI
Apr. 29	Sun Pharmaceutical Industries Limited Company Receives an Order Passed by Jt. Commissioner, CGST and Central Excise	CI